Global Vascular Grafts Market

Global Vascular Grafts Market Size Insights Forecasts to 2035

• The Global Vascular Grafts Market Size Was Estimated at USD 3.45 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.18 % from 2025 to 2035
• The Worldwide Vascular Grafts Market Size is Expected to Reach USD 6.67 Billion by 2035
• Europe is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Vascular Grafts Market Size Was Worth Around USD 3.45 Billion In 2024 And Is Predicted To Grow To Around USD 6.67 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 6.18 % From 2025 To 2035. One major driver of the market's expansion is the rising prevalence of vascular illnesses, such as peripheral artery disease (PAD), coronary artery disease (CAD), chronic kidney disease (CKD), and aneurysms. The rising incidence of end-stage renal disease (ESRD), the growing frequency of cardiovascular diseases, technological developments, and an increase in surgical operations are some of the contributing causes to the high market growth.

 

Market Overview

A vascular graft is a medical device that acts as a substitute, repair, or rerouting of the damaged or infected blood vessels so that the blood flow can return to normal. Generally, it can be made from synthetic materials, biological tissues, or their combination. Such grafts are mostly applied in the treatment of cardiovascular diseases, aneurysms, and hemodialysis access. These innovations result in improved long-term patency and surgical outcomes, which in turn bring about higher acceptance from vascular surgeons. Vascular grafts serve as medical devices that are essentially tubes, either synthetic or biological in nature and are instrumental in the replacement of or bypass of the damaged, blocked, or diseased blood vessels, hence normalisation of the flow of blood. They can be made of Dacron (polyethene terephthalate), expanded polytetrafluoroethylene (ePTFE), polyurethane, or autologous veins, which are considered to be very compatible with the biological system and at the same time very strong. The grafts also have to be resistant to thrombosis and infection, as well as having long-term patency, so as to be able to provide sufficient organ perfusion and at the same time prevent the occurrence of complications such as restenosis. With the development of tissue-engineered and bioactive grafts, endothelialisation is supported for improved integration and durability.

 

Xeltis secured an additional €12.5 million in funding from the European Innovation Council (EIC) Fund to advance the clinical development of its aXess vascular graft, bringing total Series D2 financing to €44.5 million. The funding supports ongoing trials across Europe for patients with chronic kidney disease requiring hemodialysis.

 

Swedish biotech company VERIGRAFT secured €1.2 million in funding from the Eurostars program to accelerate the development of its 3D?printed arterial grafts, aimed at transforming vascular surgery with personalised regenerative solutions.

 

Report Coverage

This research report categorises the vascular grafts market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the vascular grafts market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the vascular grafts market.     

 

Driving Factors  

The vascular graft market is undergoing significant changes as a result of technological advancements and a rise in demand for efficient treatment options. New materials and manufacturing methods are making vascular grafts perform better and last longer, which is very helpful for patients who need bypass surgeries or vascular reconstructions. The market is moving towards using more natural and long-lasting graft materials that can significantly improve patient satisfaction and bring down complications. Besides innovative technology, the vascular graft market is also affected by regulatory changes and shifting healthcare policies. To meet tough safety and efficacy standards, which may even lead to a total change in product lines, manufacturers are preparing for these regulations. Moreover, the growing attention on less invasive surgical methods will probably result in a demand for newer graft designs that make it easier for the surgeon to implant the device and the patient to recover. In general, the market for vascular grafts seems to be on the path to continuous expansion with a huge focus on innovation and patient, centric solutions that effectively deal with the intricacies of vascular health.

 

Restraining Factors  

The market for vascular grafts is constrained by high procedure costs, the possibility of infection or graft failure, all of which prevent broad use and impede market growth. The market for vascular grafts is constrained by risks of infection or graft rejection, and demanding regulatory approval procedures, all of which restrict widespread adoption in developing healthcare markets.

 

Market Segmentation    

The vascular grafts market share is classified into product, and raw material.     

 

• The endovascular stent grafts segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.        

Based on the product, the vascular grafts market is differentiated into hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aortic disease, and peripheral vascular grafts. Among these, the endovascular stent grafts segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An endovascular stent graft is a tube made of fabric that is held up by a metal mesh stent. These grafts are frequently utilised to treat a variety of blood artery disorders, such as thoracic and abdominal aortic aneurysms. Their broad use and market domination are partly due to their capacity to deliver efficient treatment while minimising patient stress and recuperation time.

• The synthetic vascular grafts segment accounted for the highest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.      

Based on the raw material, the vascular grafts market is divided into synthetic vascular grafts, biological vascular grafts, and hybrid vascular grafts. Among these, the synthetic vascular grafts segment accounted for the highest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Vascular grafts made of polyester are a major part of this market. These grafts are a common option for vascular procedures since they are made of polyester fabric, a synthetic material known for its strong mechanical qualities. Moreover, the availability of polyester vascular grafts from these major companies is expected to propel growth in this market.

 

Regional Segment Analysis of the Vascular Grafts Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

Asia Pacific is anticipated to hold the largest share of the vascular grafts market over the predicted timeframe.     

Asia Pacific is anticipated to hold the largest share of the vascular grafts market over the predicted timeframe. The major contributing factors to the growth are upgraded healthcare systems, the increasing elderly population, and the rise in the number of patients with cardiovascular and renal diseases. Greater awareness, government support, and technology innovations in surgical care are the essentials behind the positive trend in the regional market. The trend of using the most recent graft technologies in the region is also a factor in the long, term market growth.

 

China's vascular graft market is growing rapidly because of easier access to healthcare and the increasing number of old people. The increasing incidences of vascular and heart diseases, along with the government's plea for investments in medical infrastructure, are pushing the demand even further.

 

Europe is expected to grow at a rapid CAGR in the vascular grafts market during the forecast period. Europe is known as a mature market for vascular grafts, where the main source of growth is the increasing healthcare expenditures and medically advanced technology being widely accepted. There is an ongoing market expansion of non-invasive procedures that do not rely on synthetic grafts, which is posing a real challenge to the surgical solutions, particularly in the treatment of obstructed coronary and peripheral vascular diseases.

 

Among the European nations, Germany holds the biggest market mainly because of its top-notch healthcare facilities and a high level of adoption of leading-edge vascular repair devices. The focus on precision medicine and clinical research in the country is the main reason for the availability of high-performance grafts.

 

Competitive Analysis:   

The report offers the appropriate analysis of the key organizations/companies involved within the vascular grafts market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

 

List of Key Companies

• Abbott
• B. Braun Melsungen AG.
• BD (Becton Dickinson)
• Cook medical
• Endologix
• Getinge AB
• LeMaitre Vascular, Inc.
• Medtronic
• MicroPort Scientific Corporation
• Shanghai suokang medical implants Co limited
• Terumo Corporation
• W. L. Gore and Associates, Inc.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

 

Recent Development

 

• In March 2025, Scientists at the University of Wisconsin–Madison and the Morgridge Institute for Research developed stem cell–based vascular grafts that could transform cardiac surgery by providing “off-the-shelf” bioengineered arteries, reducing reliance on patient-harvested or donor vessels. These grafts show promise in bypass procedures, offering improved compatibility and durability.

 

• In January 2025, Cornell University researchers developed a new biodegradable vascular graft that mimics natural arteries and veins, offering hope for millions of cardiovascular patients by enabling safer, more effective treatments for smaller blood vessels. Other national and regional financing has been sparked by the Cornell sponsorship.

 

• In December 2024, the U.S. FDA approved Symvess, the first acellular tissue-engineered vessel (ATEV), for treating vascular trauma in extremities when urgent revascularisation is needed, and autologous vein grafts are not feasible. This marks a major milestone in trauma care, offering an off-the-shelf biologic option to prevent limb loss.

 

Market Segment  

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the vascular grafts market based on the below-mentioned segments: 

  

Global Vascular Grafts Market, By Product

• Hemodialysis Access Grafts
• Endovascular Stent Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts

 

Global Vascular Grafts Market, By Raw Material

• Synthetic Vascular Grafts
• Biological Vascular Grafts
• Hybrid Vascular Grafts

 

Global Vascular Grafts Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the projected size and growth rate of the global vascular grafts market?

The market was valued at USD 3.45 billion in 2024 and is expected to reach USD 6.67 billion by 2035, growing at a CAGR of 6.18% from 2025 to 2035.

 

2. What are the main drivers of growth in the vascular grafts market?

Key drivers include the rising prevalence of vascular diseases like PAD, CAD, CKD, and aneurysms, increasing ESRD cases, cardiovascular disease frequency, technological advancements, and more surgical procedures.

 

3. Which product segment dominates the vascular grafts market?

Endovascular stent grafts held the largest share in 2024 and are expected to grow at a significant CAGR, due to their use in treating aneurysms with minimal patient stress and faster recovery.

 

4. What raw material segment leads the market by revenue?

Synthetic vascular grafts, particularly polyester-based ones, accounted for the highest revenue share in 2024 and are projected to grow strongly, thanks to their mechanical strength and availability from major companies.

 

5. Which region is expected to hold the largest market share?

Asia-Pacific is anticipated to dominate over the forecast period, driven by upgraded healthcare systems, ageing populations, rising cardiovascular and renal diseases, government support, and surgical innovations—especially in China.

 

6. Which region will see the fastest growth?

Europe is projected to grow at the fastest CAGR, fueled by high healthcare spending, advanced technology adoption, and a mature market, with Germany leading due to superior facilities and precision medicine.

 

7. Who are the key players in the vascular grafts market?

Major companies include Abbott, B. Braun Melsungen AG, BD (Becton Dickinson), Cook Medical, Endologix, Getinge AB, LeMaitre Vascular, Medtronic, MicroPort Scientific Corporation, Shanghai Suokang Medical Implants, Terumo Corporation, and W. L. Gore & Associates.